Recent News

522 News Items found
In the Lab
Scientists at the Sloan Kettering Institute are learning why some immune cells are stubbornly hard to revive with immunotherapy.
Why Immune Cells Sometimes Fail to Fight Cancer (and What to Do about It)
By looking at how DNA is packaged in cells, scientists are teasing apart a long-standing conundrum about the immune response to cancer.
Announcement
MSK Symposium Honors Dinshaw Patel, Titan of Structural Biology
MSK Symposium Honors Dinshaw Patel, Titan of Structural Biology
Scientists came to MSK to celebrate the 75th birthday of a leader in the field of structural biology.
graduation boutonnieres
Seven Gerstner Sloan Kettering Students Prepare to Graduate in 2017
Seven students have successfully defended their dissertations and will receive their PhD degrees at commencement on May 18.
In the Lab
Cancer biologist and pediatric oncologist Alex Kentsis
Jumping Genes and the Dark Genome: MSK Researchers Gain New Insight into Childhood Cancers
Researchers have discovered a genetic mechanism that may trigger most childhood cancers.
Mount Rushmore viewed through face-detection software.
Making a Splash: Researchers Apply Face-Detection Technology to the Study of Genes
Taking a cue from smartphone technology, scientists are using face-recognition algorithms to improve RNA interference.
In the Lab
A cell in the process of dividing
New Study Shows How Wayward Chromosomes Get Back on Track
MSK researchers are learning how cells are able to recognize and correct errors that occur during cell division.
In the Lab
An illustration of CRISPR-Cas9
A Cut Above: MSK-Developed Software Makes CRISPR More Precise
A freely accessible software program provides researchers with an easy way to optimize a popular genome-editing tool.
In the Lab
Wearable device on woman’s arm with labels indicating beams going into nanotubes and coming back out for analysis.
Detective Work: How Implantable Nanosensors Could Monitor Cancer Activity
Learn how tiny sensors made of nanotubes could serve as implantable devices that offer a noninvasive way to monitor cancer and its treatments.
Feature
Molecular biologist John Petrini of the Sloan Kettering Institute.
Understanding the DNA-Damage “First Responders”: John Petrini at Work
Scientists know that cancer can result from mistakes in DNA repair. But understanding what controls the repair process itself has been a hard nut to crack.
In the Lab
CAR T cells attacking cancer
CRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level
What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.